Chan Zuckerberg Initiative (CZI) Science Program Officer Katja Brose visited JAX to speak about CZI and moderate an Alzheimer’s disease research panel discussion at the JAX Healthcare Forum, an annual gathering of leaders in a wide variety of healthcare fields. JAX was able to catch up with Dr. Brose after her sessions.
Breast cancer risk assessment is increasingly included in primary care. As a rule of thumb, approximately 5-10% of individuals with a breast cancer diagnosis will be found to carry a pathogenic variant (mutation).
Researchers from JAX, UConn Health, and Connecticut Children’s sent genetically-engineered “Mighty Mice” to the International Space Station to learn about the effect of microgravity on muscle and bone loss.